Treatment of T-AYU-HM Premium and Onion steam vaporisation on possible re-infection or reactivation Covid-19 patient: A case study
Abstract
During the coronavirus pandemic, we are at stage where now observations are being recorded for possibilities of reinfection or reactivation in patients suffered from coronavirus. The heterogeneous natures of coronavirus infection producing complications in patients require a lot of critical care and monitoring. Post-discharge from hospitals, proper self-care and immune booster supplements have become a must. Patient's self-immunity, post-discharge medication non-adherence, casual approaches in self-care might become reasons for reinfection or reactivation of the virus in patients. Reporting case studies on reinfection or reactivation of coronavirus help enhance post-discharge management and safety guidelines. A 50-year-old male infected with coronavirus was admitted to the hospital, receiving treatment and discharge after 10 days. A 2 months later due to difficulty breathing, coughing, and fever he presented to our clinic. On examination and laboratory investigation, it was considered possible reinfection or reactivation of coronavirus in a patient. With proper discussion and prior consent we initiate treatment with T-AYU-HM premium and onion steam vaporization. During follow-up visit the observations like clinical and laboratory markers suggest remarkable improvement and alleviation of symptoms. During 2 months of treatment adherence, we also observed a marked decrease in lung opacities and no honeycombing in HRCT than in previous reports. This case report recommends the importance of an alternative medicine system restricted to the prophylactic purpose and has a role to play in post covid19 infected patients.
Keywords:
Covid-19, Recurrence, Re-infection, T-AYU-HM Premium, Onion steam vaporisationDOI
https://doi.org/10.25004/IJPSDR.2021.130116References
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar; 579(7798):270-273.
Vetta F, Vetta G, Bracchitta S, Mignano M, Mattatelli A. Cardiac resynchronization therapy in the elderly. How far is it safe and beneficial? Monaldi Arch Chest Dis. 2019; 89(1); 41-43.
Vetta F, Vetta G. The key role of comorbidities in the outcome of elderly patients with implantable cardioverter defibrillator. Journal of Cardiology and Cardiovascular diseases. 2019; 1 (1): 1-5.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020; 323(13):1239-1242.
Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect.2020; 80:e14–e1717.
Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis, The Lancet Microbe, 2020.
Cheng K, Wei M, Shen H, Wu C, Chen D, Xiong W, et al. Clinical characteristics of 463 patients with common and severe type coronavirus disease (In Chinese) Shanghai Med J (2020), pp. 1-15
Xiong Y, Sun D, Liu Y, et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol. 2020; 55(6):332-339.
Desai A, Desai H, Desai C, Desai R. Possible Role of T-Ayu-Hm Premium and Other Herbal Drug Treatments In Covid19, IJSDR- 2020; 5(4), 272 – 274.
Desai A, Desai K, Desai H, Desai C, Desai R. A case report study on effectiveness of TAYU-HM Premium tablet and Onion steam vaporisation in Covid-19 patient Patient. J Pharm Sci Bioscientific Res. 2020. 10(3):180-182.
Desai A, Desai K, Desai H, Desai C, Desai R. A Case Report on the Effects of Onion Steam Vapour/Nebulisation and T-AYU-HM Premium Tablets in Covid-19 Patient. J Pharm Sci Bioscientific Res. 2020. 10(2):171-174.
Desai AM, Saraf MN, Desai C, Desai H, Dalal M. Clinical Evaluation of T-AYU-HM in the management of Sickle Cell Anemia. IJPSR 2018; 9(8): 3573-3578.
Liu CH, Ji MR, Fang X, Wang HY, Lin GF. Peripheral leukocytes in psoriasis. Int J Dermatol. 1988 Nov;27(9):638-41.
Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-1797.
Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020; 80:e14–e1717.
Ling Y, Xu S-.B, Lin Y-.X, Tian D, Zhu Z-.Q, Dai F-H. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020;133(9):1039–1043.
Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in False- Negative Rate of Reverse Transcriptase Polymerase Chain Reaction– Based SARS-CoV-2 Tests by Time Since Exposure. Annuals of Internal Medicine. May 13, 2020.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. hydroxychloroquine and azithromycin as a treatment of COVID- 19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949.
Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J. Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment. J Am Acad Dermatol. 2020;83(2):579-586.
Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Hydroxychloroquine with or without Azithromycin in Mild-to- Moderate Covid-19, N Engl J Med 2020; 383:2041-2052.
Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARSCoV-2 in patients with COVID-19. Nat Med. 2020; 26:845-848.
Vitiello A, Pelliccia C, Ferrara F. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN Compr. Clin. Med. 2020; 2: 1709–1712.
Ang L, Song E, Lee HW, Lee MS. Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2020;9(5):1583.
Desai A, Desai H, Desai C, Desai J, Mansuri A. Possible Role of Medicinal Plants In Covid-19: A Brief Review, IJSDR,2020; 5(4):205- 209.
Published

